Genetically Proxied Glucose-lowering Drug Target and Risk of Immune Mediated Inflammatory Disease: A Mendelian Randomization Study

被引：0
|
作者：
Wu, Dongze [1 ]
Jin, Yingzhao [2 ]
机构：
[1] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Rheumatol & Immunol, Chengdu, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Peoples R China
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2049
引用
收藏
页码：4152 / 4154
页数：3
相关论文
共 50 条
  • [21] Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk
    Sun, Xiaohui
    Ping, Jie
    Guo, Xingyi
    Long, Jirong
    Cai, Qiuyin
    Shu, Xiao-ou
    Shu, Xiang
    MOLECULAR CARCINOGENESIS, 2024, 63 (05) : 849 - 858
  • [22] Genetically Proxied Therapeutic Effect of Metformin Use, Blood Pressure, and Hypertension's Risk: a Drug Target-Based Mendelian Randomization Study
    Jiang, Junhong
    Hu, Di
    Zhang, Qi
    Lin, Zenan
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2024, 17 (03) : 716 - 722
  • [23] Association between genetically proxied glucosamine and risk of cancer and non-neoplastic disease: A Mendelian randomization study
    Wu, Yingtong
    Che, Yinggang
    Zhang, Yong
    Xiong, Yanlu
    Shu, Chen
    Jiang, Jun
    Li, Gaozhi
    Guo, Lin
    Qiao, Tianyun
    Li, Shuwen
    Li, Ou
    Chang, Ning
    Zhang, Xinxin
    Zhang, Minzhe
    Qiu, Dan
    Xi, Hangtian
    Li, Jinggeng
    Chen, Xiangxiang
    Ye, Mingxiang
    Zhang, Jian
    FRONTIERS IN GENETICS, 2024, 15
  • [24] Association between genetically proxied lipid-lowering drug targets, lipid traits, and amyotrophic lateral sclerosis: a mendelian randomization study
    Yan, Zhaoqi
    Xu, Yifeng
    Li, Keke
    Liu, Liangji
    ACTA NEUROLOGICA BELGICA, 2024, 124 (02) : 485 - 494
  • [25] Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study
    Cai, Dihui
    Zheng, Zequn
    Hu, Jiale
    Fu, Yin
    Song, Yongfei
    Lian, Jiangfang
    CLINICAL RHEUMATOLOGY, 2024, 43 (01) : 533 - 541
  • [26] Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study
    Dihui Cai
    Zequn Zheng
    Jiale Hu
    Yin Fu
    Yongfei Song
    Jiangfang Lian
    Clinical Rheumatology, 2024, 43 : 533 - 541
  • [27] Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
    Yarmolinsky, James
    Diez-Obrero, Virginia
    Richardson, Tom M.
    Pigeyre, Marie E.
    Sjaarda, Jennifer Y.
    Pare, Guillaume
    Walker, Venexia
    Vincent, Emma
    Tan, Vanessa
    Obon-Santacana, Mireia
    Albanes, Demetrius K.
    Hampe, Jochen
    Gsur, Andrea
    Hampel, Heather
    Pai, Rish
    Jenkins, Mark I.
    Gallinger, Steven
    Casey, Graham M.
    Zheng, Wei
    Amos, Christopher
    Smith, George Davey
    Martin, Richard
    Moreno, Victor
    PRACTICAL consortium
    MEGASTROKE consortium
    PLOS MEDICINE, 2022, 19 (02)
  • [28] Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian randomization analysis
    Yao, Zehui
    Qin, Dailei
    Cao, Jianzhong
    Gao, Chun
    Xi, Pu
    Li, Shengping
    Wei, Ran
    BMC CANCER, 2025, 25 (01)
  • [29] Association between genetically proxied lipid-lowering drug targets, lipid traits, and amyotrophic lateral sclerosis: a mendelian randomization study
    Zhaoqi Yan
    Yifeng Xu
    Keke Li
    Liangji Liu
    Acta Neurologica Belgica, 2024, 124 : 485 - 494
  • [30] Association Between Genetically Proxied SLC12A2 Inhibition and Inflammatory Bowel Disease: A Mendelian Randomization Study
    Yu, Xin
    Cao, Yongsheng
    Mao, Changkun
    Tao, Chengpin
    Chen, Wei
    BIOCHEMICAL GENETICS, 2025,
12345